Hercules Capital (HTGC)

The company is best known for serving innovation-led sectors, including software, internet and consumer technology, hardware, semiconductors, networking, medical devices, biotechnology, pharmaceuticals, and other life sciences markets. This positioning gives Hercules exposure to companies that may be growing quickly but are often not yet suited to conventional bank financing. Loans are commonly tailored to the needs of venture-stage businesses and may include warrants or other features that allow Hercules to participate in some upside if a borrower performs well.

Hercules aims to generate income for shareholders through interest and fee income from its credit portfolio while also preserving net asset value through underwriting and collateral protection. Its model depends on access to capital, disciplined credit selection, relationships with venture capital sponsors, and the health of the broader venture financing environment. For investors, HTGC represents a listed way to gain exposure to private technology and life sciences credit, with risks tied to borrower performance, interest rates, portfolio valuations, and the availability of growth funding across the venture ecosystem.